Lysine-Cysteine-Serine-Tryptophan inserted into the DNA-binding domain of human mineralocorticoid receptor increases transcriptional activation by aldosterone
The Journal of Steroid Biochemistry and Molecular Biology · 2024
DOI: 10.1016/j.jsbmb.2024.106548 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Steroid Biochemistry and Molecular Biology, 2024. Verfasst von Yoshinao Katsu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Hokkaido University, Sapporo, Japan; Graduate School of Life Science, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Receptors, Mineralocorticoid, Aldosterone, Transcriptional Activation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Takeda Science Foundation, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Due to alternative splicing in an ancestral DNA-binding domain (DBD) of the mineralocorticoid receptor (MR), humans contain two almost identical MR transcripts with either 984 amino acids (MR-984) or 988 amino acids (MR-988), in which their DBDs differ by only four amino acids, Lys,Cys,Ser,Trp (KCSW). Human MRs also contain mutations at two sites, codons 180 and 241, in the amino terminal domain (NTD). Together, there are five distinct full-length human MR genes in GenBank. Human MR-984, which was cloned in 1987, has been extensively studied. Human MR-988, cloned in 1995, contains KCSW in its DBD. Neither this human MR-988 nor the other human MR-988 genes have been studied for their response to aldosterone and other corticosteroids. Here, we report that transcriptional activation of human MR-988 by aldosterone is increased by about 50 % compared to activation of human MR-984 in HEK293 cells transfected with the TAT3 promoter, while the half-maximal response (EC50) is similar for aldosterone activation of MR-984 and MR-988. Transcriptional activation of human MR also depends on the amino acids at codons 180 and 241. Interestingly, in HEK293 cells transfected with the MMTV promoter, transcriptional activation by aldosterone of human MR-988 is similar to activation of human MR-984, indicating that the promoter has a role in the regulation of the response of human MR-988 to aldosterone. The physiological responses to aldosterone and other corticosteroids in humans with MR genes containing KCSW and with differences at codons 180 and 241 in the NTD warrant investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Science, Hokkaido University, Sapporo, Japan; Graduate School of Life Science, Hokkaido University, Sapporo, Japan.
- Graduate School of Life Science, Hokkaido University, Sapporo, Japan.
- Division of Nephrology-Hypertension, Department of Medicine, 0693, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA 92093, USA; Center for Academic Research and Training in Anthropogeny (CARTA) Unive…
Förderung
- Takeda Science Foundation
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Katsu, Y., Zhang, J., & Baker, M. E. (2024). Lysine-Cysteine-Serine-Tryptophan inserted into the DNA-binding domain of human mineralocorticoid receptor increases transcriptional activation by aldosterone. The Journal of Steroid Biochemistry and Molecular Biology. https://doi.org/10.1016/j.jsbmb.2024.106548
Vancouver
Katsu Y, Zhang J, Baker ME. Lysine-Cysteine-Serine-Tryptophan inserted into the DNA-binding domain of human mineralocorticoid receptor increases transcriptional activation by aldosterone. The Journal of Steroid Biochemistry and Molecular Biology. 2024. doi:10.1016/j.jsbmb.2024.106548
BibTeX
@article{Katsu2024,
author = {Katsu, Yoshinao and Zhang, Jiawen and Baker, Michael E},
title = {Lysine-Cysteine-Serine-Tryptophan inserted into the DNA-binding domain of human mineralocorticoid receptor increases transcriptional activation by aldosterone},
journal = {The Journal of Steroid Biochemistry and Molecular Biology},
year = {2024},
doi = {10.1016/j.jsbmb.2024.106548}
}
EUVIMED